Work

Abstract 3811: Drug discovery of potent and specific CDK9 protein degraders for the treatment of refractory lymphomas

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3811

Authors: Yu Xue, Vivian Jiang, Haiying Chen, Hong Kim, Tianci Zhang, Qingsong Cai, Lei Nie, Joseph McIntosh, Yang Liu, Michael Wang, Jia Zhou

Institutions: The University of Texas Medical Branch at Galveston, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627424

Cites:

Cited by:

Related to: 10